相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis
Madison J. Kelly et al.
NATURE COMMUNICATIONS (2019)
The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions
Hamid Bolouri et al.
NATURE MEDICINE (2018)
Crosstalk in competing endogenous RNA network reveals the complex molecular mechanism underlying lung cancer
Xiang Jin et al.
ONCOTARGET (2017)
PU.1 downregulation in murine radiation-induced acute myeloid leukaemia (AML): from molecular mechanism to human AML
Tom Verbiest et al.
CARCINOGENESIS (2015)
miR-155 regulative network in FLT3 mutated acute myeloid leukemia
Domenico Salemi et al.
LEUKEMIA RESEARCH (2015)
Influence of radiation quality on mouse chromosome 2 deletions in radiation-induced acute myeloid leukaemia
Natalie Brown et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2015)
Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia
Britta Will et al.
NATURE MEDICINE (2015)
Aberrantly expressed miR-582-3p maintains lung cancer stem cell-like traits by activating Wnt/β-catenin signalling
Lishan Fang et al.
NATURE COMMUNICATIONS (2015)
NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia
D. Gerloff et al.
LEUKEMIA (2015)
Aldosterone Regulates MicroRNAs in the Cortical Collecting Duct to Alter Sodium Transport
Robert S. Edinger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia
Catalina A. Palma et al.
MOLECULAR CANCER (2014)
Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice
P. Basova et al.
ONCOGENE (2014)
PredictSNP: Robust and Accurate Consensus Classifier for Prediction of Disease-Related Mutations
Jaroslav Bendl et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cells
Hiromichi Yuki et al.
BLOOD (2013)
Live cell detection of chromosome 2 deletion and Sfpi1/PU1 loss in radiation-induced mouse acute myeloid leukaemia
C. -H. Olme et al.
LEUKEMIA RESEARCH (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Incidence of Leukemia, Lymphoma and Multiple Myeloma among Atomic Bomb Survivors: 1950-2001
Wan-Ling Hsu et al.
RADIATION RESEARCH (2013)
DNA methylation-mediated silencing of PU.1 in leukemia cells resistant to cell differentiation
Maria Jose Fernandez-Nestosa et al.
SPRINGERPLUS (2013)
MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status
Isabella Faraoni et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
Flt3-ITD mutations in a mouse model of radiation-induced acute myeloid leukaemia
R. Finnon et al.
LEUKEMIA (2012)
MicroRNA expression and activity in pediatric acute lymphoblastic leukemia (ALL)
Jaqueline C. de Oliveira et al.
PEDIATRIC BLOOD & CANCER (2012)
Global DNA Demethylation During Mouse Erythropoiesis in Vivo
Jeffrey R. Shearstone et al.
SCIENCE (2011)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
Yingzi Wang et al.
SCIENCE (2010)
High-throughput mutational screen of the tyrosine kinome in chronic myelomonocytic leukemia
J. W. Tyner et al.
LEUKEMIA (2009)
Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia
D. Schotte et al.
LEUKEMIA (2009)
MicroRNA Patterns Associated with Clinical Prognostic Parameters and CNS Relapse Prediction in Pediatric Acute Leukemia
Hua Zhang et al.
PLOS ONE (2009)
Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder
Ryan M. O'Connell et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Down-regulation of PU.1 by methylation of distal regulatory elements and the promoter is required for myeloma cell growth
Hiro Tatetsu et al.
CANCER RESEARCH (2007)
Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells
Ulrich Steidl et al.
NATURE GENETICS (2006)
BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas
J Kluiver et al.
JOURNAL OF PATHOLOGY (2005)
Mutations of the PU.1 Ets domain are specifically associated with murine radiation-induced, but not human therapy-related, acute myeloid leukaemia
N Suraweera et al.
ONCOGENE (2005)
Activation of the RAS pathway is predictive for a chemosensitive phenotype of acute myelogenous leukemia blasts
T Illmer et al.
CLINICAL CANCER RESEARCH (2005)
Potential autoregulation of transcription factor PU.1 by an upstream reaulatory element
Y Okuno et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Accumulation of miR-155 and BIC RNA in human B cell lymphomas
PS Eis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
PU. 1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain
WD Cook et al.
BLOOD (2004)
Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML
C Schoch et al.
LEUKEMIA (2004)
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1
F Rosenbauer et al.
NATURE GENETICS (2004)
Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics:: a study of the AML Study Group Ulm
S Fröhling et al.
BLOOD (2002)
Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice
SC Kogan et al.
BLOOD (2002)
FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia
DL Stirewalt et al.
BLOOD (2001)
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
Y Yamamoto et al.
BLOOD (2001)